These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 75895)

  • 1. Alterations of clotting factors and platelets during hemofiltration.
    Köstering H; Girndt J; Matthaei D; Naidu R; Quellhorst E
    J Dial; 1977; 1(6):607-17. PubMed ID: 75895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha1-antitrypsin and alpha2-macroglobulin in newborn infants. II. Relation to the coagulation system.
    Göbel U; Triebel A; Petrich C; von Voss H
    Eur J Pediatr; 1978 Sep; 129(2):125-32. PubMed ID: 79487
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
    Vaziri ND; Gonzales EC; Wang J; Said S
    Am J Kidney Dis; 1994 Jun; 23(6):828-35. PubMed ID: 8203365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelations between ABO blood group, plasminogen, alpha1-antitrypsin, alpha2-macroglobulin and the platelet count in blood donors.
    Dawson A; Allardyce M; Allan TM; Ogston D; Kerridge DF; Lewis HB
    Acta Haematol; 1976; 56(1):19-26. PubMed ID: 60867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in coagulation fibrinolytic factors in cerebral thrombosis].
    Inaba H
    Nihon Ika Daigaku Zasshi; 1987 Dec; 54(6):631-41. PubMed ID: 2449449
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disorders of blood coagulatiion during haemoperfusion (author's transl)].
    Niessner H; Pichler M
    Wien Klin Wochenschr; 1977 May; 89(10):347-50. PubMed ID: 68628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo.
    Noda Y; Nakamura M; Sasaki M; Kosugi T
    Auris Nasus Larynx; 1986; 13 Suppl 1():S75-9. PubMed ID: 2429647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of fibrinolytic and coagulation factors during open heart surgery. I. Fibrinolytic problems during open heart surgery with ECC.
    Kladetzky RG; Popov-Cenić S; Büttner W; Müller N; Egli H
    Thromb Res; 1975 Oct; 7(4):579-8. PubMed ID: 53897
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombin III and fibrinolysis during pregnancy and oral contraceptive therapy].
    Laursen B; Herbst TV; Ewald EC; Pedersen SC
    Ugeskr Laeger; 1976 Feb; 138(6):344-8. PubMed ID: 56073
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemostatic defects in polycythaemia vera.
    Stathakis NE; Papayannis AG; Arapakis G; Gardikas C
    Blut; 1974 Aug; 29(2):77-86. PubMed ID: 4852216
    [No Abstract]   [Full Text] [Related]  

  • 11. A new assay for the measurement of total progressive antithrombin.
    Lane JL; Bird P; Rizza CR
    Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dihydroergotamine on coagulation factors and components of the fibrinolytic system.
    Svanberg L; Bernstein K; Kullander S; Astedt B
    Acta Obstet Gynecol Scand; 1980; 59(3):251-3. PubMed ID: 6158827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of smoking on the haemostatic mechanism in pregnancy.
    Condie RG; Pirani BB
    Acta Obstet Gynecol Scand; 1977; 56(1):5-8. PubMed ID: 65896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional fibrinolytic study in coronary artery disease.
    Patrassi GM; Bisetti P; Chioin R; Procidano M; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):307-12. PubMed ID: 6179833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
    Tsianos EB; Stathakis NE
    Thromb Haemost; 1980 Dec; 44(3):130-4. PubMed ID: 6162208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke.
    Fletcher AP; Alkjaersig N; Davies A; Lewis M; Brooks J; Hardin W; Landau W; Raichle ME
    Stroke; 1976; 7(4):337-48. PubMed ID: 60807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in protease inhibitors after acute myocardial infarction.
    Rennie JA; Crawford GP; Ogston D
    J Clin Pathol; 1976 Jul; 29(7):639-41. PubMed ID: 61974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of various blood coagulation and hemorrheological parameters in arteriosclerotic vascular disease of the lower legs].
    Avellone G; Mandalà V; Novo S; Pinto A; Davì G; Raneli G; Strano A
    Ric Clin Lab; 1983; 13 Suppl 3():297-301. PubMed ID: 6200915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis and antithrombin in acute leukaemia.
    Laursen B
    Dan Med Bull; 1976 May; 23(2):81-6. PubMed ID: 59658
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rehabilitation in myocardial infarct. Study of various coagulation parameters and platelet function].
    Gibelli A; Fiorini GF; Renoldi P; Schweiger C; Piazza A; Paracchini ML
    Minerva Med; 1983 May; 74(21):1279-84. PubMed ID: 6190108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.